Natural Products and their Bioactives in Antidiabetic Drug Discovery (EPUB)

6 $

Delivery time: Maximum to 1 hours

Format : EPUB

File Size : 13 MB

The book “Natural Products and their Bioactives in Antidiabetic Drug Discovery” provides an overview of recent research in new drug discovery against diabetic complications based on bioactives from natural products. It covers topics such as Type-1 Diabetes, Type-2 Diabetes, and gestational DM prevention and management with natural compounds. The book is essential for researchers and professionals involved in drug discovery and development, health care, medicinal chemistry, phytochemistry, plant science, and toxicology. The publisher is Wiley, and the book has 352 digital pages and an ISBN of 978-1119983316.

Category: Medical Book

Description

Natural Products and their Bioactives in Antidiabetic Drug Discovery (EPUB)

By Kanti Bhooshan Pandey, Maitree Suttajit, Pinar Atukeren

Introduction: The pursuit of effective solutions for diabetes management has led to an exploration of natural products and their bioactive components as potential sources of antidiabetic agents. “Natural Products and their Bioactives in Antidiabetic Drug Discovery” delves into recent research that highlights the application of bioactive compounds from natural sources in the prevention and treatment of diabetes-related complications. By bridging the gap between public research institutions and private enterprises, this work contributes to the advancement of drug discovery efforts in the antidiabetic realm.

Key Features: This book provides an overview of key developments in the domain of antidiabetic drug discovery, focusing on the utilization of bioactive compounds derived from natural products. The content is structured to enhance reader comprehension and engagement, incorporating case studies and illustrative examples within relevant chapters.

Fundamental Concepts and Drug Discovery Progress: The initial section offers insights into the fundamentals of diabetes mellitus (DM) and recent strides in drug discovery. It examines the diverse druggable targets and associated challenges.
Bioactive Compounds Targeting Type-1 Diabetes: The second part concentrates on bioactive compounds with potential efficacy against Type-1 Diabetes, offering insights into their mechanisms of action and therapeutic implications.
Addressing Type-2 Diabetes: Part three explores the role of bioactive compounds in managing Type-2 Diabetes, shedding light on their pharmacological mechanisms and therapeutic benefits.
Gestational Diabetes Prevention and Management: The fourth section centers on the use of natural compounds to prevent and manage gestational diabetes, presenting a holistic approach to addressing this unique form of diabetes.

Target Audience: “Natural Products and their Bioactives in Antidiabetic Drug Discovery” appeals to a diverse audience including researchers, professionals, and practitioners engaged in various disciplines. It provides valuable insights to individuals in drug discovery and development, health care, medicinal chemistry, phytochemistry, plant science, and toxicology.

Conclusion: In the quest for innovative antidiabetic solutions, the integration of natural products and bioactive compounds holds immense promise. This publication underscores the significance of harnessing these natural sources to tackle the challenges posed by diabetes-related complications. By fostering collaboration between research institutions and commercial entities, this work propels the evolution of antidiabetic drug discovery, contributing to improved healthcare outcomes and advancements in the field of diabetes management.